Ceftazidime Export Market Intelligence: India's 228 Suppliers Shipping to 99 Countries — TransData Nexus 2026

Q: Who are the top ceftazidime exporters from India?

The top ceftazidime exporters from India are: 1. ZEISS PHARMACEUTICALS PRIVATE LIMITED — $2.1M (19.5% market share); 2. ANANTA MEDICARE LIMITED — $1.6M (14.9% market share); 3. VENUS REMEDIES LIMITED — $722.5K (6.8% market share); 4. THEON PHARMACEUTICALS LIMITED — $338.3K (3.2% market share); 5. SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI — $225.7K (2.1% market share). Together they account for 46.4% of India's total ceftazidime export value.

Q: What is the total export value of ceftazidime from India?

The total export value of ceftazidime from India is $10.7M USD, recorded across 920 shipment transactions from 228 active exporters to 99 destination countries. The average shipment value is $11.6K.

Q: Which countries import ceftazidime from India?

India exports ceftazidime to 99 countries worldwide. The top importing countries are: GHANA (19.5% share, $2.1M), UKRAINE (14.3% share, $1.5M), SUDAN (8.0% share, $850.9K), FRANCE (3.9% share, $416.6K), MYANMAR (3.7% share, $397.4K). These five markets account for 49.4% of total export value.

Q: What is the HS code for ceftazidime exports from India?

The primary HS code for ceftazidime exports from India is 30042019. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ceftazidime exports from India?

The average unit price for ceftazidime exports from India is $17.38 USD per unit, with prices ranging from $0.00 to $510.00 depending on formulation, packaging, and order volume. The total market is valued at $10.7M across 920 shipments.

Q: Which ports handle ceftazidime exports from India?

The primary ports for ceftazidime exports from India are SAHAR AIR (12.8% of shipments), SAHAR AIR CARGO ACC (INBOM4) (11.1% of shipments), NHAVA SHEVA SEA (INNSA1) (9.6% of shipments), DELHI AIR (7.8% of shipments), DELHI AIR CARGO ACC (INDEL4) (6.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ceftazidime?

India is one of the world's leading exporters of ceftazidime due to its large base of 228 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ceftazidime to 99 countries, demonstrating 51% global market coverage.

Q: What certifications do Indian ceftazidime exporters need?

Indian ceftazidime exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ceftazidime from India?

There are 360 registered buyers importing ceftazidime from India, spread across 99 countries. The repeat buyer rate is 44.7%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ceftazidime supplier from India?

ZEISS PHARMACEUTICALS PRIVATE LIMITED is the leading ceftazidime exporter from India with a market share of 19.5% and total export value of $2.1M across 8 shipments. The top 5 suppliers together control 46.4% of total export value.

Suresh Sormare

Ceftazidime

India Pharmaceutical Trade Intelligence

$10.7M228 Suppliers99 CountriesHS 30042019

ExportsIndia → GHANA19.5%India → UKRAINE14.3%

ImportsITALY → India$52.7M BELGIUM → India$327.7K

Ceftazidime Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ceftazidime to the World

Between 2022 and 2026, India exported $10.7M worth of ceftazidime across 920 verified shipments to 99 countries — covering 51% of world markets in the Advanced Antibiotics segment. The largest destination is GHANA (19.5%). ZEISS PHARMACEUTICALS PRIVATE LIMITED leads with a 19.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Ceftazidime export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ceftazidime export data snapshot — $10.7M · 228 exporters · 99 countriesTransData Nexus · Indian Customs Data

Top Ceftazidime Exporters from India

228 active exporters · Ranked by export value

View all 228 →

Top Ceftazidime Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ZEISS PHARMACEUTICALS PRIVATE LIMITED	$2.1M	8	1	19.5%
2	ANANTA MEDICARE LIMITED

Top Countries Importing Ceftazidime from India

99 destination markets · Ranked by import value

All 99 countries →

Top Countries Importing Ceftazidime from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	GHANA	$2.1M	19.5%
2	UKRAINE	$1.5M	14.3%
3	SUDAN	$850.9K	8.0%
4	FRANCE	$416.6K	3.9%
5	MYANMAR	$397.4K	3.7%
6	PHILIPPINES	$352.3K	3.3%
7	TAJIKISTAN	$330.0K	3.1%
8	NIGERIA	$317.5K	3.0%
9	SOUTH AFRICA	$290.4K	2.7%
10	KENYA	$255.4K	2.4%

GHANA is India's largest ceftazidime export destination, absorbing 19.5% of total exports worth $2.1M. The top 5 importing countries — GHANA, UKRAINE, SUDAN, FRANCE, MYANMAR — together account for 49.4% of India's total ceftazidime export value. The remaining 94 destination countries collectively receive the other 50.6%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Ceftazidime to India?

11 origin countries · Total import value: $53.2M

India imports ceftazidime from 11 countries with a combined import value of $53.2M. The largest supplier is ITALY ($52.7M, 56 shipments), followed by BELGIUM and UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Ceftazidime to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	ITALY	$52.7M	56	99.0%
2	BELGIUM	$327.7K	1	0.6%
3	UNITED STATES	$109.7K	15	0.2%
4	IRELAND	$64.3K	5	0.1%
5	BRAZIL	$11.6K	1	0.0%
6	GERMANY	$2.7K	1	0.0%
7	MALAYSIA	$1.8K	1	0.0%
8	UNITED ARAB EMIRATES	$913	2	0.0%
9	UNITED KINGDOM	$20	1	0.0%
10	SRI LANKA	$6	1	0.0%

Showing top 10 of 11 origin countries

ITALY is the largest supplier of ceftazidime to India, accounting for 99.0% of total import value. The top 5 origin countries — ITALY, BELGIUM, UNITED STATES, IRELAND, BRAZIL — together supply 100.0% of India's ceftazidime imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Ceftazidime

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, the Food and Drug Administration (FDA) oversees the approval and regulation of ceftazidime through the Abbreviated New Drug Application (ANDA) pathway. This process allows manufacturers to market generic versions of previously approved drugs, ensuring they meet stringent standards for bioequivalence, safety, and efficacy. The FDA's Orange Book provides a comprehensive list of approved drug products, including ceftazidime, detailing the number of approved ANDAs and their respective approval dates.

Importantly, the FDA maintains vigilance over imported pharmaceuticals to protect public health. The agency issues Import Alerts to identify products that may violate FDA regulations, leading to detention without physical examination (DWPE) of such products. As of March 2026, there are no active Import Alerts specifically targeting ceftazidime from Indian manufacturers, indicating compliance with FDA standards. However, with 228 active Indian exporters of ceftazidime, it is imperative for each to adhere strictly to FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), ceftazidime is subject to rigorous regulatory oversight. The European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) require that manufacturers obtain marketing authorization before distributing ceftazidime. This process involves a thorough evaluation of the drug's quality, safety, and efficacy. Additionally, compliance with Good Manufacturing Practice (GMP) standards is mandatory, ensuring that ceftazidime is consistently produced and controlled according to quality standards.

3WHO Essential Medicines & Global Standards

Ceftazidime is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in addressing priority health needs globally. The 24th edition of this list, published in September 2025, continues to recognize ceftazidime's critical role in treating severe bacterial infections. This inclusion serves as a guideline for countries to develop their own national essential medicines lists, promoting access to vital treatments. Furthermore, ceftazidime is listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and formulation across different regions.

4India Regulatory Classification

In India, ceftazidime is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including ceftazidime, to ensure affordability. As of March 2026, the ceiling price for ceftazidime is set by the NPPA, reflecting the government's commitment to making essential medicines accessible. For exporters, obtaining a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) is a prerequisite, ensuring that exports comply with national regulations and do not compromise domestic availability.

5Patent & Exclusivity Status

Ceftazidime's primary patents have expired, allowing for the production and marketing of generic versions. This has led to increased competition among manufacturers, contributing to the drug's affordability and widespread availability. The absence of active patents facilitates the entry of multiple players into the market, promoting innovation and cost-effectiveness in production.

6Recent Industry Developments

In the past 12 months, several key developments have impacted the ceftazidime market:

1. API Price Fluctuations (June 2025): The NPPA reported a 5% increase in the price of Active Pharmaceutical Ingredients (APIs) for ceftazidime, attributed to rising raw material costs.

2. Regulatory Approval (September 2025): The EMA granted marketing authorization for a new generic formulation of ceftazidime, expanding treatment options within the EU.

3. Policy Update (December 2025): The CDSCO revised guidelines for antibiotic manufacturing, emphasizing stricter compliance with GMP standards to enhance product quality.

4. Export Policy Change (February 2026): The DGFT introduced a streamlined process for obtaining export NOCs for antibiotics, including ceftazidime, to facilitate international trade.

5. WHO Prequalification (March 2026): A leading Indian manufacturer achieved WHO prequalification for its ceftazidime product, enhancing its credibility in global markets.

These developments reflect a dynamic regulatory environment and underscore the importance of continuous monitoring to navigate the complexities of the pharmaceutical industry effectively.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ceftazidime

Retail & reference prices across 9 markets vs. India FOB export price of $17.38/unit

Global Price Benchmark for Ceftazidime across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$1.20 per 500 mg	USD	According to the FDA, ceftazidime is available in injectable forms, including 500 mg vials.
United Kingdom	Approximately $5.30 per 500 mg	GBP	As per the NHS Drug Tariff, the reimbursement price for a 500 mg vial of ceftazidime is £4.25.
Germany	N/A	EUR	Specific pricing information for ceftazidime in Germany is not readily accessible from public government sources.
Australia	N/A

Supply Chain Risk Assessment — Ceftazidime

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Ceftazidime, a third-generation cephalosporin antibiotic, is primarily produced in India and China. India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and intermediates, with approximately 70% of these imports originating from China. This dependency exposes the supply chain to risks associated with geopolitical tensions, trade restrictions, and environmental regulations in China.

In recent years, China's stringent environmental policies have led to the shutdown of several API manufacturing facilities, causing supply disruptions and increased costs. Such events underscore the vulnerability of India's pharmaceutical supply chain due to its reliance on Chinese KSMs.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Ceftazidime account for 46.4% of total exports, with ZEISS PHARMACEUTICALS PRIVATE LIMITED leading at a 19.5% share. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact global supply.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic production of critical APIs and reduce import dependence. The scheme has led to the establishment of new manufacturing units for essential molecules, potentially decreasing reliance on foreign sources.

Access Complete Ceftazidime Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 920 transactions across 99 markets.

Request Demo View Pricing

Frequently Asked Questions — Ceftazidime Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ceftazidime exporters from India?

The leading ceftazidime exporters from India are ZEISS PHARMACEUTICALS PRIVATE LIMITED, ANANTA MEDICARE LIMITED, VENUS REMEDIES LIMITED, and 12 others. ZEISS PHARMACEUTICALS PRIVATE LIMITED leads with 19.5% market share ($2.1M). The top 5 suppliers together control 46.4% of total export value.

What is the total export value of ceftazidime from India?

The total export value of ceftazidime from India is $10.7M, recorded across 920 shipments from 228 active exporters to 99 countries. The average shipment value is $11.6K.

Which countries import ceftazidime from India?

India exports ceftazidime to 99 countries. The top importing countries are GHANA (19.5%), UKRAINE (14.3%), SUDAN (8.0%), FRANCE (3.9%), MYANMAR (3.7%), which together account for 49.4% of total export value.

What is the HS code for ceftazidime exports from India?

The primary HS code for ceftazidime exports from India is 30042019. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ceftazidime

Ceftazidime

Top Ceftazidime Exporters from India

Top Countries Importing Ceftazidime from India

Who Supplies Ceftazidime to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Ceftazidime

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ceftazidime

Supply Chain Risk Assessment — Ceftazidime

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ceftazidime Trade Intelligence

Frequently Asked Questions — Ceftazidime Exports from India

Who are the top ceftazidime exporters from India?

What is the total export value of ceftazidime from India?

Which countries import ceftazidime from India?

What is the HS code for ceftazidime exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ceftazidime exports from India?

Which ports handle ceftazidime exports from India?

Why is India a leading exporter of ceftazidime?

What certifications do Indian ceftazidime exporters need?

How many buyers import ceftazidime from India?

What is the market share of the top ceftazidime exporter from India?

Analysis Methodology